Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Pain management in opioid maintenance treatment.

Koller G, Schwarzer A, Halfter K, Soyka M.

Expert Opin Pharmacother. 2019 Aug 16:1-13. doi: 10.1080/14656566.2019.1652270. [Epub ahead of print]

PMID:
31418602
2.

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

Labuhn M, Perkins K, Matzk S, Varghese L, Garnett C, Papaemmanuil E, Metzner M, Kennedy A, Amstislavskiy V, Risch T, Bhayadia R, Samulowski D, Hernandez DC, Stoilova B, Iotchkova V, Oppermann U, Scheer C, Yoshida K, Schwarzer A, Taub J, Crispino JD, Weiss MJ, Hayashi A, Taga T, Ito E, Ogawa S, Reinhardt D, Yaspo ML, Campbell PJ, Roberts I, Constantinescu S, Vyas P, Heckl D, Klusmann JH.

Cancer Cell. 2019 Aug 12;36(2):123-138.e10. doi: 10.1016/j.ccell.2019.06.007. Epub 2019 Jul 11.

PMID:
31303423
3.

The heteroscorpionate ligand 2,2-bis(3,5-dimethylpyrazol-1-yl)-1,1-diphenylethanol and an easy preparation of its tungsten complex.

Böhme U, Schwarzer A, Günther B.

Acta Crystallogr C Struct Chem. 2019 Jul 1;75(Pt 7):996-1001. doi: 10.1107/S2053229619008362. Epub 2019 Jun 25.

PMID:
31271390
4.

Intensity of Withdrawal Symptoms During Opioid Taper in Patients with Chronic Pain-Individualized or Fixed Starting Dosage?

Bienek N, Maier C, Kaisler M, Michel-Lauter B, Schwarzer A, Meyer-Frießem CH.

Pain Med. 2019 Feb 26. pii: pny320. doi: 10.1093/pm/pny320. [Epub ahead of print]

PMID:
30806672
5.

The influence of environmental enrichment and stocking density on the plumage and health conditions of laying hen pullets.

Liebers CJ, Schwarzer A, Erhard M, Schmidt P, Louton H.

Poult Sci. 2019 Jun 1;98(6):2474-2488. doi: 10.3382/ps/pez024.

6.

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.

Hüttmann A, Rekowski J, Müller SP, Hertenstein B, Franzius C, Mesters R, Weckesser M, Kroschinsky F, Kotzerke J, Ganser A, Bengel FM, La Rosée P, Freesmeyer M, Höffkes HG, Hertel A, Behringer D, Prange-Krex G, Griesshammer M, Holzinger J, Wilop S, Krohn T, Raghavachar A, Maschmeyer G, Brink I, Schroers R, Gaska T, Bernhard H, Giagounidis A, Schütte J, Dienst A, Hautzel H, Naumann R, Klein A, Hahn D, Pöpperl G, Grube M, Marienhagen J, Schwarzer A, Kurch L, Höhler T, Steiniger H, Nückel H, Südhoff T, Römer W, Brinkmann M, Ose C, Alashkar F, Schmitz C, Dürig J, Hoelzer D, Jöckel KH, Klapper W, Dührsen U.

Ann Hematol. 2019 Apr;98(4):897-907. doi: 10.1007/s00277-018-3578-0. Epub 2019 Jan 4.

PMID:
30610279
7.

First onset of a left-bundle-branch ventricular tachycardia in an elderly: A rare cause.

Kirsch K, Schöne K, Jahnke C, Pätzsch I, Schwarzer A, Monecke A, Thiele H, Sandri M.

Cardiol J. 2018;25(6):749-750. doi: 10.5603/CJ.2018.0153. No abstract available.

8.

We miss the opportunity: Pretreament of osteoporosis in a German trauma center.

Rausch V, Schwarzer A, Dietrich JW, Kaisler M, Seybold D, Vollert J, Schildhauer TA, Maier C.

PLoS One. 2018 Nov 12;13(11):e0207122. doi: 10.1371/journal.pone.0207122. eCollection 2018.

9.

[Pharmacological Basis of Pain Treatment].

Schüning J, Schwarzer A.

Dtsch Med Wochenschr. 2018 Sep;143(19):1363-1371. doi: 10.1055/a-0584-9667. Epub 2018 Sep 19. Review. German.

PMID:
30231283
10.

Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions.

Heidel FH, Al-Ali HK, Hirt C, Kämpfe D, Jentsch-Ullrich K, Junghanss C, Nowak R, Schwarzer A, Spohn C, Vucinic V, Hochhaus A, Lange T; Working Party Myeloproliferative Neoplasms of the East German Study Group Hematology/Oncology (OSHO).

Leukemia. 2018 Sep;32(9):2085-2087. doi: 10.1038/s41375-018-0214-x. Epub 2018 Jul 24. No abstract available.

PMID:
30042412
11.

Opioid intake prior to admission is not increased in elderly patients with low-energy fractures: A case-control study in a German hospital population.

Schwarzer A, Kaisler M, Kipping K, Seybold D, Rausch V, Maier C, Vollert J.

Eur J Pain. 2018 Oct;22(9):1651-1661. doi: 10.1002/ejp.1247. Epub 2018 Jun 4.

PMID:
29758586
12.

Different supramolecular interactions mediated by Br atoms in the crystal structures of three anisole derivatives.

Nestler R, Schwarzer A, Gruber T.

Acta Crystallogr C Struct Chem. 2018 Mar 1;74(Pt 3):283-288. doi: 10.1107/S2053229618001997. Epub 2018 Feb 6.

PMID:
29504555
13.

Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.

Bhayadia R, Krowiorz K, Haetscher N, Jammal R, Emmrich S, Obulkasim A, Fiedler J, Schwarzer A, Rouhi A, Heuser M, Wingert S, Bothur S, Döhner K, Mätzig T, Ng M, Reinhardt D, Döhner H, Zwaan CM, van den Heuvel Eibrink M, Heckl D, Fornerod M, Thum T, Humphries RK, Rieger MA, Kuchenbauer F, Klusmann JH.

J Clin Oncol. 2018 Apr 1;36(10):1007-1016. doi: 10.1200/JCO.2017.75.2204. Epub 2018 Feb 12.

PMID:
29432078
14.

Seronegative alveolar echinococcosis in a patient with multiple myeloma.

Lübbert C, Reinhardt F, Karlas T, Schwarzer A, Riese F, Schmidt T, Bartels M.

Int J Infect Dis. 2018 Apr;69:47-49. doi: 10.1016/j.ijid.2018.02.001. Epub 2018 Feb 6. No abstract available.

15.

Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practice.

Reiser M, Dörfel S, Hensel M, Hoesl M, Jordan WO, Koenigsmann M, Meyer D, Reichert D, Schwarzer A, Marquardt M, Kellershohn K, Jentsch-Ullrich K.

Eur J Haematol. 2018 May;100(5):455-464. doi: 10.1111/ejh.13040. Epub 2018 Mar 22.

PMID:
29393986
16.

Pooled Generation of Lentiviral Tetracycline-Regulated microRNA Embedded Short Hairpin RNA Libraries.

Adams FF, Hoffmann T, Zuber J, Heckl D, Schambach A, Schwarzer A.

Hum Gene Ther Methods. 2018 Feb;29(1):16-29. doi: 10.1089/hgtb.2017.182.

PMID:
29325442
17.

Development of a prognostic tool for the occurrence of feather pecking and cannibalism in laying hens.

Kaesberg AU, Louton H, Erhard M, Schmidt P, Zepp M, Helmer F, Schwarzer A.

Poult Sci. 2018 Mar 1;97(3):820-833. doi: 10.3382/ps/pex369.

PMID:
29294110
18.

Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications.

Labuhn M, Adams FF, Ng M, Knoess S, Schambach A, Charpentier EM, Schwarzer A, Mateo JL, Klusmann JH, Heckl D.

Nucleic Acids Res. 2018 Feb 16;46(3):1375-1385. doi: 10.1093/nar/gkx1268.

19.

[Pain treatment with opioids for non-cancer pain by the family physician].

Schüning J, Maier C, Schwarzer A.

MMW Fortschr Med. 2017 Nov;159(Suppl 3):52-61. doi: 10.1007/s15006-017-9599-0. German. No abstract available.

PMID:
29086255
20.

Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.

Geis FK, Galla M, Hoffmann D, Kuehle J, Zychlinski D, Maetzig T, Schott JW, Schwarzer A, Goffinet C, Goff SP, Schambach A.

Retrovirology. 2017 Oct 18;14(1):48. doi: 10.1186/s12977-017-0372-3.

21.

Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).

Beck J, Schwarzer A, Gläser D, Mügge LO, Uhlig J, Heyn S, Kragl B, Mohren M, Hoffmann FA, Lange T, Schliwa T, Zehrfeld T, Becker C, Kreibich U, Winkelmann C, Edelmann T, Andrea M, Bill M, Jentzsch M, Schwind S, Niederwieser D, Pönisch W.

J Cancer Res Clin Oncol. 2017 Dec;143(12):2545-2553. doi: 10.1007/s00432-017-2504-5. Epub 2017 Aug 21.

PMID:
28828689
22.

The non-coding RNA landscape of human hematopoiesis and leukemia.

Schwarzer A, Emmrich S, Schmidt F, Beck D, Ng M, Reimer C, Adams FF, Grasedieck S, Witte D, Käbler S, Wong JWH, Shah A, Huang Y, Jammal R, Maroz A, Jongen-Lavrencic M, Schambach A, Kuchenbauer F, Pimanda JE, Reinhardt D, Heckl D, Klusmann JH.

Nat Commun. 2017 Aug 9;8(1):218. doi: 10.1038/s41467-017-00212-4.

23.

A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.

Beck D, Thoms JAI, Palu C, Herold T, Shah A, Olivier J, Boelen L, Huang Y, Chacon D, Brown A, Babic M, Hahn C, Perugini M, Zhou X, Huntly BJ, Schwarzer A, Klusmann JH, Berdel WE, Wörmann B, Büchner T, Hiddemann W, Bohlander SK, To LB, Scott HS, Lewis ID, D'Andrea RJ, Wong JWH, Pimanda JE.

Leukemia. 2018 Feb;32(2):263-272. doi: 10.1038/leu.2017.210. Epub 2017 Jul 4.

PMID:
28674423
24.

Evaluation of welfare parameters in laying hens on the basis of a Bavarian survey.

Louton H, Bergmann SM, Rauch E, Liebers C, Reese S, Erhard MH, Hoeborn C, Schwarzer A.

Poult Sci. 2017 Sep 1;96(9):3199-3213. doi: 10.3382/ps/pex156.

PMID:
28651355
25.

An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA libraries.

Adams FF, Heckl D, Hoffmann T, Talbot SR, Kloos A, Thol F, Heuser M, Zuber J, Schambach A, Schwarzer A.

Biomaterials. 2017 Sep;139:102-115. doi: 10.1016/j.biomaterials.2017.05.032. Epub 2017 May 23.

PMID:
28599149
26.

Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.

Geis FK, Galla M, Hoffmann D, Kuehle J, Zychlinski D, Maetzig T, Schott JW, Schwarzer A, Goffinet C, Goff SP, Schambach A.

Retrovirology. 2017 May 31;14(1):34. doi: 10.1186/s12977-017-0358-1. Erratum in: Retrovirology. 2017 Oct 18;14(1):48.

27.

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.

Mey UJ, Brugger W, Schwarb H, Pederiva S, Schwarzer A, Dechow T, Jehner P, Rauh J, Taverna CJ, Schmid M, Schmidt-Hieber M, Doerfel S, Fischer N, Ruefer A, Ziske C, Knauf W, Cathomas R, von Moos R, Hitz F, Sauter R, Hiendlmeyer E, Cantoni N, Bargetzi M, Driessen C.

Br J Haematol. 2017 Mar;176(5):770-782. doi: 10.1111/bjh.14481. Epub 2016 Dec 16.

PMID:
27983764
28.

Changes of the Sensory Abnormalities and Cortical Excitability in Patients with Complex Regional Pain Syndrome of the Upper Extremity After 6 Months of Multimodal Treatment.

Enax-Krumova EK, Lenz M, Frettlöh J, Höffken O, Reinersmann A, Schwarzer A, Westermann A, Tegenthoff M, Maier C.

Pain Med. 2017 Jan 1;18(1):95-106. doi: 10.1093/pm/pnw147.

PMID:
27425192
29.

Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate.

Chaturvedi A, Araujo Cruz MM, Jyotsana N, Sharma A, Goparaju R, Schwarzer A, Görlich K, Schottmann R, Struys EA, Jansen EE, Rohde C, Müller-Tidow C, Geffers R, Göhring G, Ganser A, Thol F, Heuser M.

Leukemia. 2016 Aug;30(8):1708-15. doi: 10.1038/leu.2016.71. Epub 2016 Apr 11.

30.

Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.

Heinz N, Ehrnström B, Schambach A, Schwarzer A, Modlich U, Schiedlmeier B.

Stem Cells Transl Med. 2015 Sep;4(9):1064-72. doi: 10.5966/sctm.2014-0284. Epub 2015 Jul 9.

31.

Inhibition of Thrombopoietin/Mpl Signaling in Adult Hematopoiesis Identifies New Candidates for Hematopoietic Stem Cell Maintenance.

Kohlscheen S, Wintterle S, Schwarzer A, Kamp C, Brugman MH, Breuer DC, Büsche G, Baum C, Modlich U.

PLoS One. 2015 Jul 6;10(7):e0131866. doi: 10.1371/journal.pone.0131866. eCollection 2015.

32.

Sequential Therapy for Helicobacter pylori Infection in Treatment-naïve Children.

Schwarzer A, Bontems P, Urruzuno P, Kalach N, Iwanczak B, Roma-Giannikou E, Sykora J, Kindermann A, Casswall T, Cadranel S, Koletzko S.

Helicobacter. 2016 Apr;21(2):106-13. doi: 10.1111/hel.12240. Epub 2015 Jun 30.

PMID:
26123402
33.

Sleep-disordered breathing decreases after opioid withdrawal: results of a prospective controlled trial.

Schwarzer A, Aichinger-Hinterhofer M, Maier C, Vollert J, Walther JW.

Pain. 2015 Nov;156(11):2167-74. doi: 10.1097/j.pain.0000000000000279.

PMID:
26121253
34.

Lentiviral vector system for coordinated constitutive and drug controlled tetracycline-regulated gene co-expression.

Stahlhut M, Schwarzer A, Eder M, Yang M, Li Z, Morgan M, Schambach A, Kustikova OS.

Biomaterials. 2015 Sep;63:189-201. doi: 10.1016/j.biomaterials.2015.06.022. Epub 2015 Jun 16.

PMID:
26113075
35.

Two reversible enantiotropic phase transitions in a pentacoordinate silicon complex with an O,N,O'-tridentate valinate ligand.

Schwarzer A, Fels S, Böhme U.

Acta Crystallogr C Struct Chem. 2015 Jun;71(Pt 6):511-6. doi: 10.1107/S2053229615009778. Epub 2015 May 29.

PMID:
26044335
36.

Crystal structure of 4'-bromo-2,3,5,6-tetra-fluoro-biphenyl-4-carbo-nitrile.

Heckel R, Hulliger J, Schwarzer A, Weber E.

Acta Crystallogr E Crystallogr Commun. 2015 Apr 25;71(Pt 5):o347-8. doi: 10.1107/S2056989015007847. eCollection 2015 May 1.

37.

Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.

Poenisch W, Plötze M, Holzvogt B, Andrea M, Schliwa T, Zehrfeld T, Hammerschmidt D, Schwarz M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Gutsche K, Reifenrath K, Schwarzbach H, Heyn S, Franke GN, Jentzsch M, Leiblein S, Schwind S, Lange T, Vucinic V, AlAli HK, Niederwieser D.

J Cancer Res Clin Oncol. 2015 Nov;141(11):2013-22. doi: 10.1007/s00432-015-1984-4. Epub 2015 May 15.

PMID:
25976868
38.

Bortezomib-containing regimens are effective in multiple myeloma--results of a non-interventional phase IV study.

Knauf W, Tapprich C, Schlag R, Schütz S, Alkemper B, Gaede B, Reschke D, Schmits R, Schwarzer A.

Oncol Res Treat. 2015;38(4):167-73. doi: 10.1159/000381297. Epub 2015 Mar 31.

PMID:
25877940
39.

Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene.

Lai CK, Moon Y, Kuchenbauer F, Starzcynowski DT, Argiropoulos B, Yung E, Beer P, Schwarzer A, Sharma A, Park G, Leung M, Lin G, Vollett S, Fung S, Eaves CJ, Karsan A, Weng AP, Humphries RK, Heuser M.

PLoS One. 2014 Nov 17;9(11):e112671. doi: 10.1371/journal.pone.0112671. eCollection 2014.

40.

Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia.

Schwarzer A, Holtmann H, Brugman M, Meyer J, Schauerte C, Zuber J, Steinemann D, Schlegelberger B, Li Z, Baum C.

Oncogene. 2015 Jul;34(27):3593-604. doi: 10.1038/onc.2014.290. Epub 2014 Sep 22.

PMID:
25241901
41.

Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling.

Sharma A, Yun H, Jyotsana N, Chaturvedi A, Schwarzer A, Yung E, Lai CK, Kuchenbauer F, Argiropoulos B, Görlich K, Ganser A, Humphries RK, Heuser M.

Leukemia. 2015 Jan;29(1):157-68. doi: 10.1038/leu.2014.162. Epub 2014 May 20.

PMID:
24957708
42.

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.

Pönisch W, Holzvogt B, Plötze M, Andrea M, Bourgeois M, Heyn S, Zehrfeld T, Hammerschmidt D, Schwarz M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Gutsche K, Reifenrath K, Winkelmann C, Krahl R, Remane Y, Hennig E, Schliwa T, Lindner T, Kaiser T, Vucinic V, Behre G, Niederwieser D.

J Cancer Res Clin Oncol. 2014 Nov;140(11):1947-56. doi: 10.1007/s00432-014-1737-9. Epub 2014 Jun 19.

PMID:
24942335
43.

Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemia.

Yun H, Damm F, Yap D, Schwarzer A, Chaturvedi A, Jyotsana N, Lübbert M, Bullinger L, Döhner K, Geffers R, Aparicio S, Humphries RK, Ganser A, Heuser M.

Haematologica. 2014 Sep;99(9):1456-64. doi: 10.3324/haematol.2013.101386. Epub 2014 Jun 3.

44.

5,8-Bis[bis-(pyridin-2-yl)amino]-1,3,4,6,7,9,9b-hepta-aza-phenalen-2(1H)-one dimethyl sulfoxide monosolvate dihydrate.

Schwarzer A, Kroke E.

Acta Crystallogr Sect E Struct Rep Online. 2014 Mar 19;70(Pt 4):o456-7. doi: 10.1107/S1600536814005698. eCollection 2014 Apr 1.

45.

Comparison of three tests for faecal calprotectin in children and young adults: a retrospective monocentric study.

Prell C, Nagel D, Freudenberg F, Schwarzer A, Koletzko S.

BMJ Open. 2014 May 2;4(5):e004558. doi: 10.1136/bmjopen-2013-004558.

46.

Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome.

Frivolt K, Schwerd T, Werkstetter KJ, Schwarzer A, Schatz SB, Bufler P, Koletzko S.

Aliment Pharmacol Ther. 2014 Jun;39(12):1398-407. doi: 10.1111/apt.12770. Epub 2014 Apr 30.

47.

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.

Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, Modlich U, Beier R, Göhring G, Steinemann D, Fronza R, Ball CR, Haemmerle R, Naundorf S, Kühlcke K, Rose M, Fraser C, Mathias L, Ferrari R, Abboud MR, Al-Herz W, Kondratenko I, Maródi L, Glimm H, Schlegelberger B, Schambach A, Albert MH, Schmidt M, von Kalle C, Klein C.

Sci Transl Med. 2014 Mar 12;6(227):227ra33. doi: 10.1126/scitranslmed.3007280.

48.

All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinase.

Maetzig T, Kuehle J, Schwarzer A, Turan S, Rothe M, Chaturvedi A, Morgan M, Ha TC, Heuser M, Hammerschmidt W, Baum C, Schambach A.

Biomaterials. 2014 May;35(14):4345-56. doi: 10.1016/j.biomaterials.2014.01.057. Epub 2014 Feb 14.

PMID:
24529624
49.

Photochemical dimerization of a fluorinated dibenzylideneacetone in chloroform solution.

Schwarzer A, Weber E.

Acta Crystallogr C Struct Chem. 2014 Feb;70(Pt 2):202-6. doi: 10.1107/S2053229613034232. Epub 2014 Jan 9.

PMID:
24508970
50.

Medication compliance in patients with chronic pain.

Kipping K, Maier C, Bussemas HH, Schwarzer A.

Pain Physician. 2014 Jan-Feb;17(1):81-94.

Supplemental Content

Loading ...
Support Center